MS in the Media - 8 November 2019
2 - 8 November 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Medical cannabis study launched
A registry of people taking cannabis as a treatment for MS and six other conditions has been set up to gather more evidence on the effectiveness of the drug. Project Twenty21, run by Drug Science, aims to enrol 20,000 people who have been prescribed medical cannabis by their existing doctors.
Source: Sky News
Source: Drug Science
MS Trust link: Cannabis
Pain controlled by virtual reality
Using virtual reality headsets to watch Arctic scenes reduced pain and also sensitivity to painful stimuli, according to a small study of 15 healthy volunteers
Source: Medical Xpress
MS Trust link: Pain
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
